{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:45:31Z","timestamp":1790372731378,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bcmd.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T02:46:24Z","timestamp":1354761984000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Diagnosing Gaucher disease: An on-going need for increased awareness amongst haematologists"],"prefix":"10.1016","volume":"50","author":[{"given":"A.S.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2012.11.004_bb0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10038-007-0135-4","article-title":"Mutation analysis and genotype\/phenotype relationships of Gaucher disease patients in Spain","volume":"52","author":"Alfonso","year":"2007","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10238-004-0046-z","article-title":"Diagnosis, biology and treatment of hairy-cell leukaemia","volume":"4","author":"Allsup","year":"2004","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2257.2004.00630.x","article-title":"Bone marrow biopsy morbidity and mortality: 2002 data","volume":"26","author":"Bain","year":"2004","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajh.21647","article-title":"Pseudo-Gaucher cells in sickle cell anemia","volume":"85","author":"Bain","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0025","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinternmed.2010.302","article-title":"Type 1 Gaucher disease: significant disease manifestations in \"asymptomatic\" homozygotes","volume":"170","author":"Balwani","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0030","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1515\/CCLM.2002.042","article-title":"New aspects on angiotensin-converting enzyme: from gene to disease","volume":"40","author":"Baudin","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10408369109106868","article-title":"Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids","volume":"28","author":"Beneteau-Burnat","year":"1991","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0045","first-page":"747","article-title":"The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes","volume":"76","author":"Beutler","year":"1970","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0050","first-page":"85","article-title":"Gaucher disease: gene frequencies in the Ashkenazi Jewish population","volume":"52","author":"Beutler","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.V76.3.646.646","article-title":"Misuse of marrow examination in the diagnosis of Gaucher disease","volume":"76","author":"Beutler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of Glucocerebrosides. II. Evidence of an Enzymatic Deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00277-006-0176-3","article-title":"Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges","volume":"85","author":"Brody","year":"2006","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0070","article-title":"Pseudo-Gaucher cells in disseminated mycobacterial infection","author":"Busarla","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0075","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archinte.158.16.1754","article-title":"Gaucher disease: recommendations on diagnosis, evaluation, and monitoring","volume":"158","author":"Charrow","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2009.12.017","article-title":"False-positive results using a Gaucher diagnostic kit\u2013RecTL and N370S","volume":"100","author":"Choi","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0090","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2010.08167.x","article-title":"Diagnosis of severe type 1 Gaucher's disease before irreversible damage occurs: is HDL cholesterol the answer?","volume":"150","author":"Cohen","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4065\/76.5.476","article-title":"Retrospective cohort study of 148 patients with polyclonal gammopathy","volume":"76","author":"Dispenzieri","year":"2001","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcmd.2010.07.008","article-title":"Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease","volume":"46","author":"Elstein","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0115","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma","volume":"101","author":"Franco","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0120","unstructured":"P.C.E. Gaucher, De l'\u00e9pith\u00e9lioma primitif de la rate. 1882. Facult\u00e9 de M\u00e9dicine de Paris. Ref Type: Thesis\/Dissertation."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(81)90212-6","article-title":"Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity","volume":"71","author":"Gilbert","year":"1981","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V","article-title":"Platelet function abnormalities in Gaucher disease patients","volume":"61","author":"Gillis","year":"1999","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0135","first-page":"792","article-title":"Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics","volume":"85","author":"Giraldo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.gene.2012.07.011","article-title":"Screening of high-risk Gaucher disease patients in Brazil using miniaturized dried blood spots and leukocyte techniques","volume":"508","author":"Goldim","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0155","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0160","article-title":"Revised recommendations for the management of Gaucher disease in children","author":"Kaplan","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood.V33.2.379.379","article-title":"Gaucher cells in chronic myelocytic leukemia: an acquired abnormality","volume":"33","author":"Kattlove","year":"1969","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0002-9343(84)90124-4","article-title":"Immune thrombocytopenia and Gaucher's disease","volume":"77","author":"Lester","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0175","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJM197606242942609","article-title":"Elevation of serum angiotensin-converting enzyme in Gaucher's disease","volume":"294","author":"Lieberman","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0180","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.1200941109","article-title":"Gaucher disease gene GBA functions in immune regulation","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0190","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.20908","article-title":"Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention","volume":"82","author":"Mistry","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5","article-title":"Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients","volume":"55","author":"Neudorfer","year":"1997","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0200","first-page":"78","article-title":"Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients","volume":"169","author":"O'Reilly","year":"1998","journal-title":"West. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/bjc.1980.232","article-title":"Serum angiotensin-converting enzyme in malignant lymphomas, leukaemia and multiple myeloma","volume":"42","author":"Romer","year":"1980","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10545-010-9175-6","article-title":"Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy","volume":"33","author":"Stein","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10545-010-9271-7","article-title":"Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity","volume":"34","author":"Stein","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0235","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2011.059071","article-title":"Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes","author":"van Dussen","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/ajcp\/87.4.533","article-title":"Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease","volume":"87","author":"Zidar","year":"1987","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2012.11.004_bb0250","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.004_bb0255","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","article-title":"Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:42Z","timestamp":1761049782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979612002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1079979612002008"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.11.004","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosing Gaucher disease: An on-going need for increased awareness amongst haematologists","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}